Share: Nanobugs as Drugs: Bacterial Derived Nanomagnets Enhance Tumor Targeting and Oncolytic Activity of HSV‐1 Virus

Twitter Share

Nanobugs as Drugs: Bacterial Derived Nanomagnets Enhance Tumor Targeting and Oncolytic Activity of HSV‐1 Virus | Functional Magnetic Materials

https://fmm-sheffield.net/publications/nanobugs-as-drugs-bacterial-derived-nanomagnets-enhance-tumor-targeting-and-oncolytic-activity-of-hsv1-virus

LinkedIn Share

https://fmm-sheffield.net/publications/nanobugs-as-drugs-bacterial-derived-nanomagnets-enhance-tumor-targeting-and-oncolytic-activity-of-hsv1-virus

Nanobugs as Drugs: Bacterial Derived Nanomagnets Enhance Tumor Targeting and Oncolytic Activity of HSV‐1 Virus | Functional Magnetic Materials

Facebook Share

https://fmm-sheffield.net/publications/nanobugs-as-drugs-bacterial-derived-nanomagnets-enhance-tumor-targeting-and-oncolytic-activity-of-hsv1-virus

Nanobugs as Drugs: Bacterial Derived Nanomagnets Enhance Tumor Targeting and Oncolytic Activity of HSV‐1 Virus | Functional Magnetic Materials